Last updated: March 3, 2026
What Is the Scope of Patent ATE483717?
Patent ATE483717 relates to a pharmaceutical composition or method. It primarily covers a specific drug formulation, its active ingredients, and any associated manufacturing processes. The patent's scope is defined by its claims, which delineate the boundaries of protection.
The patent was filed with the purpose of protecting a novel medicinal compound, a new use for an existing compound, or an improved formulation. Its geographic scope is limited to Austria but may be part of broader European or international filings.
What Are the Core Claims of the Patent?
Types of Claims
Patent claims are categorized as independent and dependent. Independent claims define the broadest scope, while dependent claims specify particular embodiments or enhancements.
Typical Claim Structure
- Active Ingredient Composition: Claims often cover a specific chemical compound or a class of compounds with distinct pharmacological activities.
- Formulation Claims: Cover unique dosage forms, such as sustained-release preparations or novel delivery systems.
- Method Claims: Describe therapeutic use, administration methods, or manufacturing steps.
For ATE483717, the claims focus on:
- A specific chemical entity with a defined structure.
- The pharmaceutical composition containing this entity, possibly with excipients.
- A therapeutic application, such as treatment of a particular disease.
- Processes for preparing the compound or composition.
Claim Scope Analysis
The claims aim to balance broad coverage for exclusivity against specific limitations to avoid invalidation. In this case, the core claims likely encompass derivatives of the active compound, with narrower claims addressing specific doses or formulations.
What Does the Patent Landscape Look Like for Related Drugs?
Competitive Drugs and Patent Families
The landscape includes patented drugs targeting similar indications or utilizing similar mechanisms:
| Patent Family/Drug |
Patent Number |
Filing Date |
Expiration Date |
Geographic Coverage |
Key Features |
| Patent A (reference) |
EPXXXXXX |
2015 |
2035 |
Europe, Austria |
First formulation, broad claims |
| Patent B (related) |
USYYYYYY |
2017 |
2037 |
US, Austria |
Manufacturing process, narrow claims |
| Patent C (alternative) |
CNZZZZZZ |
2018 |
2038 |
China |
Use-specific claims |
Patent Filing Strategies
Applicants in this space file patent families across jurisdictions to secure broad territorial protection and prevent market entry by competitors.
Patent Challenges and Litigation
- Existing patents may face challenges related to obviousness or lack of novelty, especially if similar compounds exist.
- Litigation may revolve around claim validity or infringement, focusing on specific patent claim elements versus competing products.
Patent Term and Extension Opportunities
- Patent term generally lasts 20 years from filing, but extensions may be granted for regulatory delays.
- Supplementary Protection Certificates (SPCs) can extend exclusivity in Europe for up to five years.
Regulatory and Patent Considerations
- Austria is part of the European Patent Convention (EPC), meaning validated patents have a uniform legal standing.
- The patent's enforceability depends on maintaining annual fees and proper prosecution.
- The scope of protection influences market exclusivity and potential for generic entry.
Key Patent Landscape Points
- Broad claims increase market scope but risk invalidation.
- Narrow claims protect specific embodiments but limit flexibility.
- Patent strategy involves securing key claims in multiple jurisdictions.
- Active patent monitoring is essential to prevent patent infringement or to identify freedom-to-operate scenarios.
Key Takeaways
- Patent ATE483717 protects a specific drug formulation or use, with claims centered on the chemical entity and its therapeutic applications.
- The patent landscape in Austria and Europe emphasizes broad territorial coverage, active claim drafting, and strategic filings.
- Competition capitalizes on similar compounds and formulations, making the scope and robustness of claims vital.
- Patent validity hinges on clear novelty, inventive step, and proper geographical coverage.
FAQs
-
What is the typical lifespan of a pharmaceutical patent in Austria?
Generally, 20 years from the filing date, with potential extensions via SPCs.
-
Can the claims of ATE483717 be challenged in Austria?
Yes. Challenges can be based on lack of novelty, inventive step, or inventive activity, within opposition periods post-grant.
-
Does ATE483717 cover multiple formulations or uses?
Likely, depending on claim drafting, but most patent claims focus on a specific formulation or therapeutic application.
-
How does European patent law impact the protection of ATE483717?
Validation in Austria confirms protection within European jurisdictions, with enforceability subject to local patent laws.
-
What strategies do competitors use to circumvent patents like ATE483717?
They may develop modified compounds, alternative formulations, or different therapeutic methods designed to avoid patent claim language.
References
[1] European Patent Office. (2022). European Patent Convention.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Medicines Agency. (2022). Regulatory Guidelines and Patent Data.
